clear GGT cut-off to distinguish subjects with fatty liver and insulin resistance.
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Indones Biomed J. 2013; 5(2): 101-6 banyak dibutuhkan agar dapat menentukan cut-off GGT secara jelas sehingga dapat membedakan subyek dengan perlemakan hati dan resisten insulin.
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Subjects
Men with central obesity in Malang and Denpasar, aged 30-60 years old, WC ≥90 cm, were recruited. Medical records were obtained. Subjects with hs-CRP > 10 mg/L, estimated glomerular filtration rate (eGFR) <60 mL/minute/1.73m 2 , hepatitis B and C, cirrhosis, malignancy, vegetarian, smoking habit, and intake of alcohol, supplement, antioxidant or hepatotoxicity drugs, were excluded. This study was approved by the Ethics Committee of Hasanuddin University Faculty of Medicine (UH13020059), and written informed consent was obtained from each subject.
Blood collection and biochemical analyses
Venous blood samples were collected in the morning after 10-12 hours fasting, in plain, EDTA-contained and heparin-contained vacutainers. Plain and EDTA-contained vacutainers were then centrifuged.
Resulted serum in plain vacutainer was collected and examined for fasting glucose, hs-CRP, creatinine, GGT and fasting insulin. For fasting glucose assay, GLUC3 kit (Roche Diagnostics GmbH, Mannheim, Germany) was used. For hs-CRP assay, CRPHS kit (Roche Diagnostics GmbH, Mannheim, Germany) was used. For creatinine assay, Creatinine plus ver.2 kit (Roche Diagnostics GmbH, Mannheim, Germany) was used. Autoanalyzer Cobas Integra 400 (Roche Diagnostics, Rotkreuz, Switzerland) was applied for fasting glucose, hs-CRP and creatinine assays.
For GGT assay, GGT kit (Bayer Healthcare, Tarrytown, NY) and Autoanalyzer ADVIA 1800 (Siemens Medical Solutions Diagnostics, Tarrytown, NY) were used. For fasting insulin assay, Immulite 2000 Insulin kit (Siemens
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Obesity is one of metabolic syndrome major criteria, which related with cardiometabolic diseases, such as type 2 diabetes mellitus, hypertension and coronary heart disease.(1) Increased prevalence of obesity was closely related to prevalence of metabolic syndrome and increased cardiometabolic disease risk. Therefore, it is important to develop biomarker for observing progression from central obesity to metabolic syndrome. Gamma glutamyltransferase (GGT), mostly produced in liver(2), involved in intracellular homeostasis to resynthesis glutathione (GSH) by maintaining the availability of cysteine(3). Initially, GGT was known as a biomarker for liver disease or excessive alcohol intake, but recent reports showed that GGT could be an independent predictor of risk cardiometabolic disease.(4,5) Elevated GGT in subject with metabolic syndrome was reported to have a correlation with central obesity, resistance insulin and hepatic steatosis.(6) However, role of GGT in insulin resistance pathomechanism is not exactly known. Several studies showed correlation of GGT with inflammation, oxidative stress(7-9) and elevated amino acid (10) , that could be related with insulin resistance pathomechanism (8, 11) .
C-reactive Protein (CRP), synthesized in the liver, is not only an acute phase protein, but also a marker of chronic low grade inflammation. (12) Several studies showed association of elevated CRP level with cardiovascular disease (13) and with abdominal obesity. (14) Meanwhile, glutathione peroxidase (GPx) that involves in detoxification of H 2 O 2 and lipid peroxide by catalyzing GSH, showes its important role to defense oxidative stress.(15) Lower GPx level was reported in obese patient than healthy subject. (14) Cysteine is an essential proteinogenic amino acid containing sulfur. Plasma total cysteine (tCys) contains all forms of cysteine in the circulation including free form, disulfide and cysteine-bound albumin. (16) tCys was reported to be associated with homeostatic model assessment insulin resistance index (HOMA-IR). (11) To our current interest in finding a possible insulin resistance pathomechanism, we examined correlation of GGT with inflammation (high sensitivity CRP (hs-CRP)), oxidative stress (GPx) and elevated amino acid (tCys), in men with central obesity.
Healthcare Diagnostics, Tarrytown, NY) and Immulite 2000 (Siemens Medical Solutions Diagnostics, Flanders, NJ) were used. Resulted plasma in EDTA-contained vacutainer was collected and examined for tCys by using ClinRep Complete kit for Homocysteine in plasma (Recipe Chemicals & Instruments GmbH, Munich, Germany) and Agilent 1100 HPLC (Agilent Technologies, Waldbronn, Germany).
Venous blood in heparin-contained vacutainer was collected and examined for GPx activity by using Glutathione Peroxidase kit (Randox Laboratories Limited, Crumlin, County Antrim) and Autoanalyzer ADVIA 1800 (Siemens Medical Solutions Diagnostics, Tarrytown, NY). Each assay was performed according to the protocol provided in each kit. Fatty liver check was performed with abdominal ultrasonography (Logic 3 Pro, General Electric Co, Milwaukee, WI). Fatty liver and its grades (I, II and III) were determined by a radiologist.
Statistical analysis
Statistical analysis was performed using IBM SPSS for Windows version 19.0 (IBM Corp., Armonk, NY). All Anthropometric and biochemical characteristics of 72 men with central obesity, aged 42.4±8.7 (range: 30-60 years) and the mean of WC was 100.3±6.9 (range: 90-128 cm), were obtained and shown in Table 1 . Among the subjects with WC ≤100 cm, we found 5 subjects with fatty liver (3 subjects with fatty liver grade I and 2 subjects with fatty liver grade II). Meanwhile among the subjects with WC >100 cm, we found 17 subjects with fatty liver (4 subjects with fatty liver grade I, 5 subjects with fatty liver grade II, and 8 subjects with fatty liver grade III). All Subjects were then grouped based on WC and fatty liver: Group I: WC ≤100 cm, without fatty liver, n=33; Group II: WC ≤100 cm, with fatty liver, n=5; Group III: WC >100 cm, without fatty liver, n=17; Group IV: WC >100 cm, with fatty liver, n=17. values are expressed as mean ± standard deviation (SD), unless otherwise specified. Mann Whitney and Spearman analyses were used at a significance level of p≤0.05. Table 2 . Correlation of GGT, hs-CRP, GPx activity, tCys and HOMA-IR in different groups.
Results
Variable
Mean ± SD
*: Mann Whitney analysis; G I: Group I, G II: Group II, G III: Group III, G IV: Group IV; Significant p values were marked in bold.
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Combination of obesity with less physical activity and excessive caloric consumption would induce insulin resistance. (17) Most subjects with central obesity have insulin resistance characteristic, but not all obese would have insulin resistance syndrome. (18) GGT was reported to be associated with insulin resistance with markers of fasting insulin and HOMA-IR. (3, (19) (20) (21) In our current study, we found that GGT and HOMA-IR were significantly correlated in Group IV. Therefore, our results confirmed the previous reports, suggesting that GGT could be associated with insulin resistance, due to adiposity and ectopic fat in the liver in obese subjects. (22) In addition, our ultrasonographic results showed that subjects with higher fatty liver grade were found in Group IV comparing to Group II.
There were not significant correlations of GGT and hs-CRP, GGT and GPx, GGT and tCys, hs-CRP and HOMA-IR, GPx and HOMA-IR, since we found that our subject were included in hs-CRP middle risk (1.00-3.00 mg/L) and reference range of GPx activity (27.5-73.6 U/ gHb), suggesting that there was a homeostatic mechanism. Insulin resistance-associated obesity with excessive release of non-esterified fatty acid (NEFA) from adipose tissue into plasma and accumulated in liver, can impair insulin sensitivity. (1,3) In addition, a study conducted in children and adolescent showed positive association between tCys-NEFA and tCys-HOMA-IR. Subjects with high tCys have double-risk of insulin resistance.(11) But interestingly, in our current study, we found a significant negative correlation between tCys with HOMA-IR in Group IV. We assume that cysteine dioxygenase homeostasis mechanism might be involved, Cysteine dioxygenase has been reported to have an important role in controlling tCys level.(11) Additionally since Group IV consist of subject with non-alcoholic fatty liver disease, which means they have lower concentration of total glutathione as a results of oxidant stress, and also and lower concentrations of cysteine-glutathione disulfide. This may results the false negative correlation between tCys with HOMA-IR.
In summary, GGT was significantly positive-correlated with HOMA-IR in men with WC >100 cm and fatty liver. Further investigation with more subjects is necessary to determine clear GGT cut-off to distinguish subjects with fatty liver and insulin resistance.
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